Macrophage plasminogen activator: induction by asbestos is blocked by anti-inflammatory steroids
Abstract:
Intraperitoneal injection of asbestos fibres into mice induces the formation of exudates containing macrophages that produce plasminogen activator. Like-wise, in vitro addition of asbestos to macrophage cultures stimulates plasminogen activator secretion; the synthesis and secretion of lysozyme and lysosomal enzymes are not changed under these conditions. The enhanced secretion of plasminogen activator by macrophages exposed to asbestos is suppressed by low concentrations of anti-inflammatory steroids.
Insights
Asbestos exposure stimulates macrophages to produce plasminogen activator. Anti-inflammatory steroids can suppress this asbestos-induced plasminogen activator secretion in macrophages.
Area of Science:
- Immunology
- Toxicology
- Cell Biology
Background:
- Macrophages play a crucial role in inflammatory responses.
- Asbestos exposure is known to trigger inflammatory processes.
- Plasminogen activator is an enzyme involved in tissue remodeling and inflammation.
Purpose of the Study:
- To investigate the effect of asbestos on macrophage function.
- To determine if asbestos influences plasminogen activator secretion by macrophages.
- To examine the role of anti-inflammatory steroids in modulating asbestos-induced macrophage responses.
Main Methods:
- In vivo studies involving intraperitoneal injection of asbestos fibers into mice.
- In vitro experiments exposing macrophage cultures to asbestos.
- Assessing the production of plasminogen activator, lysozyme, and lysosomal enzymes.
- Evaluating the impact of varying concentrations of anti-inflammatory steroids.
Main Results:
- Intraperitoneal asbestos injection led to exudates with macrophages producing plasminogen activator.
- In vitro asbestos exposure stimulated plasminogen activator secretion from macrophages.
- Asbestos did not alter the synthesis or secretion of lysozyme and lysosomal enzymes.
- Low concentrations of anti-inflammatory steroids inhibited the enhanced plasminogen activator secretion induced by asbestos.
Conclusions:
- Macrophages exposed to asbestos exhibit increased secretion of plasminogen activator.
- Asbestos-induced plasminogen activator secretion is independent of changes in lysozyme and lysosomal enzyme levels.
- Anti-inflammatory steroids effectively suppress asbestos-stimulated plasminogen activator release from macrophages, suggesting a potential therapeutic target.
